The study identified four different types of pain among nursing home residents.

Published Date: 02 Mar 2023

Although it is recognized that pain is common among nursing home residents, little attention has been paid to how this pain changes over time. A new study from the Regenstrief Institute and the Indiana University School of Nursing...

Read Full News

Latest News

How New Therapies Are Reshaping HER2+ Breast Cancer

Once a uniformly aggressive subtype, HER2+ breast cancer is now a proving ground for the most innovative therapies in oncology.

Deep Dive: Treatment or Surgery First in Pancreatic Cancer?

Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it.

Should Type 2 Patients Not on Insulin Use Glucose Monitors?

While research shows some blood glucose benefits, perhaps the biggest benefit comes from lifestyle changes.

Fecal Transplant Offers No Clear Benefit in IBS

Fecal microbiota transplantation offers no clear benefit in reducing symptoms of irritable bowel syndrome, a meta-analysis finds.

AAP Guidance Seeks to Prevent Iron Deficiency Anemia

The new recommendations include universal screening for teens girls, who are at a high risk for iron deficiency and iron deficiency anemia.

Personality Symptoms May Be Linked to Nutritional Issues

Patients who report cravings, cognitive issues, or low energy may benefit from a deep nutrition examination.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

Once a uniformly aggressive subtype, HER2+ breast cancer is now a proving ground for the most innovative therapies in oncology.

Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it.

While research shows some blood glucose benefits, perhaps the biggest benefit comes from lifestyle changes.

Fecal microbiota transplantation offers no clear benefit in reducing symptoms of irritable bowel syndrome, a meta-analysis finds.

The new recommendations include universal screening for teens girls, who are at a high risk for iron deficiency and iron deficiency anemia.

Patients who report cravings, cognitive issues, or low energy may benefit from a deep nutrition examination.

News All Time

Micro- and Nanoplastics: A Multiorgan Health Threat

Once present in the body, microplastics and nanoplastics can disrupt biological barriers and contribute to diseases impacting the gastrointestinal system and beyond.

Nasal Strips: Fancy Tape or Medical Miracle?

Nasal strips flood your feed and promise better sleep. Dr Labos investigates whether nasal strips are worth the hype — or just a very convincing placebo.

Deep Dive: Is Bariatric Surgery Over?

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Parkinson’s Treatment: Are Dopamine Agonists Fading?

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.

Does Liso-Cel Offer Long-Term Survival Benefits in R/R LBCL?

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Treat or Wait, New Data on Asymptomatic Kidney Stones

Actively treating asymptomatic kidney stones is associated with lower odds of later recurrence and the need for surgery.

Australia’s New Lung Cancer Screening Enjoys High Uptake

The first year of Australia’s lung cancer screening program appears to be a success, with high uptake among its target population of heavy smokers.

Prostate Care: Quick Relief vs Retreatment

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.

Positive Topline Results for Novel LSD Formulation in MDD

A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.

The $5 Million Doctor

1 in 5 doctors say their family’s net worth has crossed $5 million.

Trofinetide Approved for Rett Syndrome After Reexamination

The EMA reverses its previous decision and grants marketing authorization to the world’s first drug specifically approved for treating the syndrome.

Carcinogen Concerns Trigger Review of Rifadin Syrup

Europe will be reviewing the tuberculosis medication following concerns raised by the Dutch medicines agency.

Pfizer Trial Backs Paxlovid Dose for High-Risk Children

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

New Parkinson’s Drug Combines Immediate and Slow Release

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

Recommended News For You

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

France Expands 2026 Vaccination Rules Amid Resurgence

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Poor agreement between diagnostic tests for breast cancer-related lymphedema

For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

Recommended Articles For You

Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances 

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Respiratory Ramifications of Systemic Disease: A Comprehensive Review 

Exploring Innovative Solutions for Infantile Hemangioma Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

2.

According to new studies, some cancer patients can safely forego radiation therapy.

3.

Second opinions don't significantly delay breast cancer treatment

4.

Pickleball program boosts health and wellness for cancer survivors, study finds

5.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

1.

Contemporary Frameworks in Oncology Across Clinical Settings

2.

Practical Concepts in Hematology and Patient Outcomes

3.

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL

4.

Epigenetic Signatures for Multi-Cancer Screening

5.

Synovial Sarcoma of Female Urethra: Case Report and Literature Review

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Efficient Management of First line ALK-rearranged NSCLC

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

3.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot